• Passa alla navigazione primaria
  • Passa al contenuto principale
  • Passa alla barra laterale primaria
MITO

MITO

Multicentre Italian Trials in Ovarian Cancer

  • Home
  • MITO
    • Cos’è MITO
    • Consiglio Direttivo MITO
    • Soci MITO
    • Centri MITO
    • Statuto e regolamento
    • Bibliografia MITO
  • Boost Your Career
  • Studi
  • Progetti
    • I Mitici Lunedì
    • Molecular Tumor Board
  • Eventi
  • Patrocini
  • Adesione al gruppo
  • Italiano
  • English

Survey Oncofertility

Survey Oncofertility

DEADLINE 12 MAGGIO 2023

The new frontiers of medicine have significantly increased cancer survival.
Healed patients wish to return to normal even if partially “invalidated” by the consequences of the therapies.
One of the most painful consequences is infertility.

Today, in Western countries, only a small percentage of cancer patients benefit from advice on the possibility of preserving fertility before starting treatments and without affecting its effectiveness. Doctors play a key role in spreading this message.
Some preservation techniques are no longer considered experimental and therefore from an ethical point of view it is unfair, and from a legal point of view it is dangerous not to give the patient detailed and complete information in this field.
Access to the preservation of fertility is part of the broader field of support, including psychological support, which is of great interest in the patient’s recovery process.

A psychological support that helps to plan life in a perspective of normality after treatment appears to be of fundamental importance, as much as the treatment itself. It has been shown that the preservation of fertility also represents an important motivation for adhering more strongly to the therapeutic path. The aim of this survey is to understand the knowledge of the oncological gynecologists of the MITO group on the new frontiers in the field of fertility preservation in patients affected by oncological pathologies.

Barra laterale primaria

Area Soci


Password dimenticata?

Password dimenticata

Annulla
SURVEY IN CORSO
Survey Oncofertility
deadline 12/05/2023
Compila la survey
Rischio sviluppo NMtr dopo PARPi
deadline prorogata
Compila la survey

PATROCINI

  • dal 12 aprile al 12 luglio
    O.P.E.R.A. GYN

    O.P.E.R.A. GYN
  • 23-24 maggio
    An Era of Breakthroughs in Gynecologic Oncology

    An Era of Breakthroughs in Gynecologic Oncology
  • 6-7 luglio 2023
    Update 2023: arcinoma dell’ovaio e dell’endometrio

    Update 2023: Carcinoma dell’ovaio e dell’endometrio

Copyright © 2023 MITO - Multicenter Italian Trial in Ovarian cancer and gynecologic malignancies · Accedi
Privacy Policy